Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy

NCT00050765 is registered in ClinicalTrials.gov with Bioheart, Inc. as lead sponsor.

NCT NCT00050765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00050765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Lead sponsor
Bioheart, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
August 31, 2006
Completion date
August 31, 2006
Enrollment
15
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, coronary artery disease, myocardial infarction